Clinical trial
Open access
Sep 2026
Evaluation of Maintenance Capecitabine Therapy After First-Line Chemotherapy in Metastatic Pancreatic Cancer.
OBJECTIVE To assess the clinical impact of maintenance capecitabine following first-line modified FOLFIRINOX in patients with metastatic pancreatic cancer (mPC), focusing on progression-free survival (PFS), overall survival (OS), quality of life (QoL), and the toxicity profile. METHODS This phase II prospective trial...
M. Shehata, A. Alhanafy, Mohamed Hassan et al.
· Asian Pacific Journal of Can... · 0 citations